Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models

Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models

Surgery followed by a chemotherapy agent is the first-line treatment for breast cancer patients. Nevertheless, new targets are required for women with triple-negative breast cancer (TNBC) in order to improve the treatment of this aggressive cancer subtype. Multiple pro-inflammatory molecules includi...

Full description

Bibliographic Details
Main Authors: Tristan Rupp, Océane Pelouin, Laurie Genest, Christophe Legrand, Guillaume Froget, Vincent Castagné
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Translational Oncology
Subjects:
Triple negative breast cancer
Preclinical models
Tumor progression
Metastasis
Fingolimod
Sphingosine-1-Phosphate
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320304186

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320304186

Similar Items